New!!- 2025 🚨 Custom Doses of Tirzepatide? What the Law Really Says

🚨 Custom Doses of Tirzepatide? What the Law Really Says! In this must-watch interview, Sara Shikhman, a nationwide telehealth and MedSpa attorney, breaks down the latest developments in the Tirzepatide FDA OFA case. She explains what the upcoming deadline really means, whether there are workarounds for compounded Tirzepatide, and what the future holds for Semaglutide and other GLP-1 medications. With millions of Americans at risk of losing access to compounded GLP-1 drugs, this is a critical time for patients and providers alike. Sara sheds light on the legal challenges, loopholes, and potential solutions in the rapidly evolving world of GLP-1 medications. 🏛️🚩⚠️ SARA and LENGEA Law LinkedIn:   / lengea   Facebook:   / lengealaw   Twitter: https://x.com/LengeaLaw Instagram:   / lengealaw   TikTok:   / sara_medspa_lawyer   YouTube:    / @sarashikhman1   💡 Don’t miss this essential update on the legal landscape of compounded GLP-1s! 🔔 Subscribe for more insights on GLP-1 medications, telehealth, and the latest in health law! 👉 Drop your questions in the comments! The Legal Battle Over Compounded Tirzepatide: What You Need to Know!